PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2, 5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl) acetamide

ML James, NP Belichenko, TVV Nguyen… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Herein we aimed to evaluate the utility of N-(2, 5-dimethoxybenzyl)-2-18F-fluoro-N-(2-
phenoxyphenyl) acetamide (18F-PBR06) for detecting alterations in translocator protein …

In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients

A Varrone, P Mattsson, A Forsberg, A Takano… - European journal of …, 2013 - Springer
Purpose Imaging the 18-kDa translocator protein (TSPO) is considered a potential tool for in
vivo evaluation of microglial activation and neuroinflammation in the early stages of …

[HTML][HTML] [18F] F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease

T Keller, FR López-Picón, A Krzyczmonik… - Nuclear Medicine and …, 2018 - Elsevier
Introduction Neuroinflammation is associated with several neurological disorders, including
Alzheimer's disease (AD). The translocator protein 18 kDa (TSPO), due to its overexpression …

Characterization of the 18 kDa translocator protein (TSPO) expression in post‐mortem normal and Alzheimer's disease brains

Y Gui, JD Marks, S Das, BT Hyman… - Brain …, 2020 - Wiley Online Library
The 18 kDa translocator protein (TSPO) is a widely used target for microglial PET imaging
radioligands, but its expression in post‐mortem normal and diseased human brain is not …

[HTML][HTML] Direct Comparison of [18F]F-DPA with [18F]DPA-714 and [11C]PBR28 for Neuroinflammation Imaging in the same Alzheimer's Disease Model Mice and …

FR López-Picón, T Keller, D Bocancea, JS Helin… - Molecular Imaging and …, 2022 - Springer
Purpose In this study we compared the recently developed TSPO tracer [18 F] F-DPA, with
[18 F] DPA-714 and [11 C] PBR28 by performing in vivo PET imaging on the same …

[HTML][HTML] [18F] GE-180 PET detects reduced microglia activation after LM11A-31 therapy in a mouse model of Alzheimer's disease

ML James, NP Belichenko, AJ Shuhendler… - Theranostics, 2017 - ncbi.nlm.nih.gov
Microglial activation is a key pathological feature of Alzheimer's disease (AD). PET imaging
of translocator protein 18 kDa (TSPO) is a strategy to detect microglial activation in vivo …

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects

A Varrone, V Oikonen, A Forsberg, J Joutsa… - European Journal of …, 2015 - Springer
Purpose Imaging of the 18-kDa translocator protein (TSPO) is a potential tool for examining
microglial activation and neuroinflammation in early Alzheimer's disease (AD).[18 F] FEMPA …

Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein

B Ji, M Ono, T Yamasaki, M Fujinaga… - Journal of Cerebral …, 2021 - journals.sagepub.com
A substantial and constitutive expression of translocator protein (TSPO) in cerebral blood
vessels hampers the sensitive detection of neuroinflammation characterized by greatly …

Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer's disease

T Keller, FR López-Picón… - Journal of Cerebral …, 2020 - journals.sagepub.com
[18F] F-DPA, a novel translocator protein 18 kDa (TSPO)-specific radioligand for imaging
neuroinflammation, has to date been synthesized with low to moderate molar activities …

In vivo imaging of microglial activation by positron emission tomography with [11C]PBR28 in the 5XFAD model of Alzheimer's disease

N Mirzaei, SP Tang, S Ashworth, C Coello, C Plisson… - Glia, 2016 - Wiley Online Library
Microglial activation has been linked with deficits in neuronal function and synaptic plasticity
in Alzheimer's disease (AD). The mitochondrial translocator protein (TSPO) is known to be …